Health Care · Euronext Paris · FYE 12-31 · Prices AT CLOSE 2026-08-18 (EUR) Last €13.72 · Day −1.15% · Mkt cap $805M · P/E (FY) 462.7× · 1Y +256.2% · Off 52W high −11.4% · Vol (1Y) 56.9% Price2023-08-18 → 2026-08-18 GNFT.PA close: EUR 3.3 on 2023-08-18 to EUR 13.7 on 2026-08-18. Split-adj closes · 240 of 4,193 · price returnⓘ At a glance No fair-value, short-interest or ownership figures on file for GNFT.PA. Key fundamentalsFY 2024 | P/E (FY)462.7× | | Sales (TTM)€70.9M | | Earnings (TTM)€1.5M | | ROE2.2% | | Net margin2.1% | | ROIC18.0% | | EPS growth 3Y−71.0% | | Sales growth 3Y−6.1% |
FY ratios · TTM sales/earnings (EUR)ⓘ Trailing returns | YTD+160.6% | | 1Y+256.2% | | 3Y+315.1% | | 5Y+312.5% | | 10Y−41.7% | | Since incept. (ann.)+4.1% |
Total return · from 2010-01-04ⓘ Risk | Ann. volatility (1Y)56.9% | | Ann. volatility (3Y)51.7% | | Sharpe (1Y)2.59 | | Sharpe (3Y)1.22 | | Max drawdown (1Y)−20.8% | | Max drawdown (3Y)−49.1% | | Beta (3Y vs SPY)−0.29 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for GNFT.PA. Latest reported quarters No reported quarters on file for GNFT.PA. Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
